Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 484 participants.
Also called NCT07613840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 484 participants
- Registry
-
NCT07613840
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07613840. Randomized; no masking; primary purpose treatment. Start 2025-04-29 (actual); primary completion 2027-04-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
- Condition
- Peripheral Arterial Disease (PAD)
- Condition
- Amputation
- Condition
- Thrombosis
- Condition
- Thrombosis (Stent Thrombosis)
- Condition
- Platelet Aggregation Inhibitors
- Condition
- Thromboelastography (TEG)
- Condition
- PRU(Platelet Reactivity Unit)
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Rivaroxaban
- Intervention (Device)
- Thromboelastography with Platelet Mapping
- Lead sponsor
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct07613840- Content hash
657031e2419a2fdbaa568f17d5add04748187ee74350b0d905222f9c4ae2de4c